The tibial neuromodulation devices market is projected to grow from USD 123.4 million in 2025 to USD 268.9 million by 2035, at a CAGR of 8.1%. Overactive Bladder will dominate with a 57.5% market share, while hospital will lead the end user segment with a 34.6% share.